Terri Gaskell (Pending Final Confirmation)CTO at Rinri TherapeuticsSpeaker
Agenda Sessions
PANEL DISCUSSION: The Platform Wars - The Future of Autologous, Allogeneic, and In Vivo Modalities
, 16:30View Session
